David W Stroman

This inventor holds 19 USPTO granted patents and 6 published patent applications, plus 4 CIPO patents and 5 EPO patents, primarily in Ophthalmic Infections. Top assignees: The Upjohn Co., Alcon Manufacturing, Ltd., Alcon Research, Ltd.. Active years: 1983-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David W Stroman. Retrieved from https://idiyas.com/inventor/david-w-stroman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 6)

% Patents Active = 84.2

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 9)

Average Co-Inventor Count = 3.5

ph-index = 8

Forward Citations = 562(Granted Patents)

Location History:

Portage, MI (US) (1983 - 1984)
Bartlesville, OK (US) (1986 - 1989)
Richardson, TX (US) (1997)
Irving, TX (US) (2002 - 2018)

Company Filing History:

Alcon Manufacturing, Ltd.

Phillips Petroleum Company

patents

6. 2 out of 28

Alcon Pharmaceuticals Ltd.

patents

7. 1 out of 366

Research Corporation Technologies, Inc.

patents

Years Active: 1983-2018

Loading Chart...

Areas of Expertise:

Ophthalmic Infections

Otic Infections

Moxifloxacin

Antibiotic Compositions

Nasal Infections

Yeast Transformation

Gene Expression

Lincomycin Nucleotides

Malaria Treatment

Pichia Pastoris

Fermentation Processes

Antibiotic Recovery

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9993483 - Compositions and methods for treating ophthalmic, octic, or nasal infections (2018-06-12),

2. 9119859 - Methods for treating otic infections (2015-09-01),

3. 8993636 - Compositions containing moxifloxacin for treating otic infections (2015-03-31),

4. 8673902 - Method of treating otic infections with moxifloxacin compositions (2014-03-18),

5. 8536167 - Methods for treating ophthalmic, otic, or nasal infections (2013-09-17),

6. 7671070 - Method of treating ophthalmic infections with moxifloxacin compositions (2010-03-02),

7. 6740664 - Methods for treating otic and ophthalmic infections (2004-05-25),

8. 6716830 - Ophthalmic antibiotic compositions containing moxifloxacin (2004-04-06),

9. 6509327 - Compositions and methods for treating otic, ophthalmic and nasal infections (2003-01-21),

10. 6440964 - Compositions and methods for treating ophthalmic and otic infections (2002-08-27),

11. 6395746 - Methods of treating ophthalmic, otic and nasal infections and attendant inflammation (2002-05-28),

12. 5665600 - Pichia pastoris linear plasmids and DNA fragments thereof (1997-09-09),

13. 4879231 - Transformation of yeasts of the genus pichia (1989-11-07),

14. 4855231 - Regulatory region for heterologous gene expression in yeast (1989-08-08),

15. 4808537 - Methanol inducible genes obtained from pichia and methods of use (1989-02-28),

Title: David W. Stroman: Innovator in Ophthalmic and Otic Treatments

Introduction

David W. Stroman, an accomplished inventor based in Irving, TX, has made significant contributions to the field of medical treatments, particularly in the area of ophthalmic, otic, and nasal infections. With 19 patents to his name, Stroman's innovative work continues to enhance healthcare options for patients suffering from various infections.

Latest Patents

Stroman's latest patents focus on compositions and methods for treating ophthalmic, otic, or nasal infections. Notably, his inventions include methods that involve treating infected tissues with compositions containing finafloxacin or its derivatives. These antimicrobial compositions are designed to effectively treat a range of infections, showcasing Stroman's commitment to advancing medical treatment methods.

Career Highlights

Throughout his career, David W. Stroman has worked with esteemed companies such as Upjohn Company and Phillips Petroleum Company. His tenure at these organizations allowed him to develop and refine his skills in innovation, leading to numerous patents that have had a lasting impact in the medical field.

Collaborations

Stroman has collaborated with several notable professionals in his field, including Gerald D. Cagle and Robert L. Abshire. These partnerships have helped facilitate the advancement of his research and contributed to his success as an inventor.

Conclusion

David W. Stroman’s inventive spirit and dedication to improving healthcare have resulted in groundbreaking treatments for infections. With his impressive portfolio of patents, he continues to be a pivotal figure in medical innovation, looking to the future to further his contributions to the field.

Profile summary based on public USPTO records.